Pallone To Walden, Burgess: Hold A Hearing On REMS Abuse, CREATES Act

July 09, 2018
House Energy & Commerce ranking Democrat Frank Pallone (NJ) on Monday (July 9) requested the committee hold a hearing examining how FDA safety systems are gamed to block generic competition and potential legislative fixes, including the pending Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act. “I would urge you to hold a hearing soon on the anti-competitive practices of pharmaceutical companies and the abuses of FDA's regulatory programs to delay generic competition. Ensuring robust competition in the pharmaceutical...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.